For research use only. Not for therapeutic Use.
Meloxicam (CAT: I004659) is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the class of oxicams. It is commonly used for the treatment of pain, inflammation, and stiffness associated with conditions such as osteoarthritis and rheumatoid arthritis. Meloxicam works by inhibiting the production of prostaglandins, which are substances involved in pain and inflammation pathways. It exerts its effects by selectively inhibiting the enzyme cyclooxygenase-2 (COX-2) while sparing cyclooxygenase-1 (COX-1). This selectivity helps to minimize the gastrointestinal side effects commonly associated with traditional NSAIDs.
| CAS Number | 71125-38-7 |
| Synonyms | Metacam; Mobic. |
| Molecular Formula | C14H13N3O4S2 |
| Purity | ≥95% |
| Target | Autophagy |
| Solubility | DMSO 30 mg/mL; Water <1 mg/mL |
| Storage | -20℃ |
| IUPAC Name | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1λ6,2-benzothiazine-3-carboxamide |
| InChI | InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19) |
| InChIKey | ZRVUJXDFFKFLMG-UHFFFAOYSA-N |
| SMILES | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
